Utilization of Biologic Disease Modifying Antirheumatic Therapy in Patients with Rheumatoid Arthritis and Recently Diagnosed Breast Cancer.

Juan Ignacio RuizXiudong LeiChi-Fang WuHui ZhaoSharon H GiordanoSuja S RajanMaria E Suarez-Almazor

Published in: Arthritis care & research (2024)

The use of tumor necrosis factor inhibitors (TNFi) and other bDMARD in patients with RA and recent BC has not increased since 2008. Glucocorticoids use remained high. Largest predictor of bDMARD utilization was prior use before BC.

Keyphrases

rheumatoid arthritis
disease activity
ankylosing spondylitis
interstitial lung disease
rheumatoid arthritis patients
stem cells
mesenchymal stem cells
idiopathic pulmonary fibrosis